195 related articles for article (PubMed ID: 29542107)
21. Time-to-Seizure Modeling of Lacosamide Used in Monotherapy in Patients with Newly Diagnosed Epilepsy.
Lindauer A; Laveille C; Stockis A
Clin Pharmacokinet; 2017 Nov; 56(11):1403-1413. PubMed ID: 28290119
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness and tolerability of lacosamide as add-on therapy in patients with brain tumor-related epilepsy: Results from a prospective, noninterventional study in European clinical practice (VIBES).
Rudà R; Houillier C; Maschio M; Reijneveld JC; Hellot S; De Backer M; Chan J; Joeres L; Leunikava I; Glas M; Grant R
Epilepsia; 2020 Apr; 61(4):647-656. PubMed ID: 32329527
[TBL] [Abstract][Full Text] [Related]
23. Lacosamide: A Review in Focal-Onset Seizures in Patients with Epilepsy.
Hoy SM
CNS Drugs; 2018 May; 32(5):473-484. PubMed ID: 29785508
[TBL] [Abstract][Full Text] [Related]
24. Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials.
Biton V; Gil-Nagel A; Isojarvi J; Doty P; Hebert D; Fountain NB
Epilepsy Behav; 2015 Nov; 52(Pt A):119-27. PubMed ID: 26414341
[TBL] [Abstract][Full Text] [Related]
25. Lacosamide: A Review in Focal Seizures in Patients with Epilepsy.
Scott LJ
Drugs; 2015 Dec; 75(18):2143-54. PubMed ID: 26607484
[TBL] [Abstract][Full Text] [Related]
26. Tolerability and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy and concomitant psychiatric conditions: Post hoc analysis of a prospective, randomized, double-blind trial.
Schmitz B; Dimova S; Zhang Y; Chellun D; De Backer M; Gasalla T
Epilepsy Res; 2020 Jan; 159():106220. PubMed ID: 31812127
[TBL] [Abstract][Full Text] [Related]
27. The challenges of assessing effectiveness of lacosamide using electronic medical record databases.
Kalilani L; Halpern R; Seare J; Dedeken P
Epilepsy Behav; 2018 Aug; 85():195-199. PubMed ID: 30032807
[TBL] [Abstract][Full Text] [Related]
28. The retention of lacosamide in patients with epilepsy and intellectual disability in three specialised institutions.
Brenner J; Majoie HJM; van Beek S; Carpay JA
Seizure; 2017 Nov; 52():123-130. PubMed ID: 29031193
[TBL] [Abstract][Full Text] [Related]
29. MONOZEB: Long-term observational study of eslicarbazepine acetate monotherapy.
Villanueva V; Bermejo P; Montoya J; Massot-Tarrús A; Galiano ML; Toledo M; Rodriguez-Uranga JJ; Bertol V; Mauri JÁ; Poza JJ; Bonet M; Castro-Vilanova MD; Ruiz-Giménez J; López-González FJ; Rodríguez-Osorio X; Tortosa-Conesa D; Ojeda J; Giner P; Garcés M; Alvarez BM; Quiroga-Subirana P; Esteve P; Baiges JJ; Hampel K
Epilepsy Behav; 2019 Aug; 97():51-59. PubMed ID: 31181429
[TBL] [Abstract][Full Text] [Related]
30. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Marson AG; Tudur Smith C
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD001911. PubMed ID: 31318037
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcomes of perampanel vs. lacosamide in cohorts of consecutive patients with severely refractory epilepsies - A monocentric retrospective analysis of systematically collected data from the German Kork Epilepsy Center.
Kurth C; Kockelmann E; Steinhoff BJ
Seizure; 2017 Feb; 45():47-51. PubMed ID: 27915111
[TBL] [Abstract][Full Text] [Related]
32. Tolerability of lacosamide or zonisamide in elderly patients with seizures.
Sarkis RA; Nicolas J; Lee JW
Seizure; 2017 Jul; 49():1-4. PubMed ID: 28486158
[TBL] [Abstract][Full Text] [Related]
33. Lacosamide for uncontrolled primary generalized tonic-clonic seizures: An open-label pilot study with 59-week extension.
Wechsler RT; Yates SL; Messenheimer J; Leroy R; Beller C; Doty P
Epilepsy Res; 2017 Feb; 130():13-20. PubMed ID: 28086164
[TBL] [Abstract][Full Text] [Related]
34. Long-term safety and efficacy following conversion to eslicarbazepine acetate monotherapy in adults with focal seizures.
Chung S; Sinha SR; Shah A; Stern JM; Cheng H; Jung J; Grinnell T; Blum D
Epilepsy Res; 2019 Jul; 153():59-65. PubMed ID: 30999260
[TBL] [Abstract][Full Text] [Related]
35. Adjunctive lacosamide in clinical practice: sodium blockade with a difference?
Stephen LJ; Kelly K; Parker P; Brodie MJ
Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421
[TBL] [Abstract][Full Text] [Related]
36. [The efficacy of lacosamide in relation to antiepileptic drug history. Clinical experiences in adult partial epilepsy].
Barcs Gábor ; Szűcs A; Horváth A; Kamondi A
Ideggyogy Sz; 2015 Jan; 68(1-2):23-9. PubMed ID: 25842913
[TBL] [Abstract][Full Text] [Related]
37. Adjunctive lacosamide--5 years' clinical experience.
Stephen LJ; Kelly K; Parker P; Brodie MJ
Epilepsy Res; 2014 Oct; 108(8):1385-91. PubMed ID: 25064538
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of lacosamide as adjunctive therapy in children with refractory epilepsy.
Yorns WR; Khurana DS; Carvalho KS; Hardison HH; Legido A; Valencia I
J Child Neurol; 2014 Jan; 29(1):23-7. PubMed ID: 23143718
[TBL] [Abstract][Full Text] [Related]
39. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
Nolan SJ; Marson AG; Weston J; Tudur Smith C
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD001904. PubMed ID: 27976799
[TBL] [Abstract][Full Text] [Related]
40. Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide.
Villanueva V; López FJ; Serratosa JM; González-Giraldez B; Campos D; Molins A; Rodriguez Uranga J; Mauri JA; Salas-Puig J; Toledo M; Sánchez-Alvarez JC; Moreno A; Serrano-Castro PJ; Saiz-Diaz RA; González de la Aleja J; de la Peña P; Asensio M
Epilepsy Behav; 2013 Nov; 29(2):349-56. PubMed ID: 23999191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
